Q2 2014

Filed Oct 17, 2014 · 10-Q · 47 days after period end · 0001193805-14-001977

Q2 2014 · 10-Q

Revenue

$0.00

— vs Q2 2013

Net Income

-$29.00K

N/M vs Q2 2013

EPS Diluted

-$0.02

N/M vs Q2 2013

Operating Income-$14,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2014	Q2 2013	Q2 2012	Q2 2011
Revenue	$0.00	$0.00	—	—
Net Income	-$29.00K	-$26.00K	-$24.00K	-$20.00K
EPS Diluted	-$0.02	-$0.02	-$0.02	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR